Episode 4: Benjamin Graham — The Father of Value Investing & His Indian Legacy | Value Investing Course
Episode 2: How the Indian Stock Market Really Works — BSE, NSE & Your Money | Value Investing Course
April 3, 2026Happy Good Friday 2026! — From Manish Goel & Multibagger Shares
April 3, 2026Episode 4: Benjamin Graham — The Father of Value Investing & His Indian Legacy
Welcome to Episode 4 of the Complete Value Investing Course for Indian Investors by Manish Goel. Today, we explore the life and teachings of Benjamin Graham, the father of value investing, and how his timeless principles create multibaggers in the Indian market even today.
Watch Episode 4 — English Version
एपिसोड 4 देखें — हिंदी संस्करण
What You Will Learn in This Episode
Benjamin Graham’s principles, written over 70 years ago, remain the foundation of every successful investor’s strategy — from Warren Buffett to Indian market legends. With the Nifty 50 around 22,700 and the Sensex near 73,300 amid current geopolitical volatility, Graham’s timeless wisdom is more relevant than ever.
Who Was Benjamin Graham? Born in 1894, Graham became a professor at Columbia Business School and authored two legendary books: Security Analysis (1934) and The Intelligent Investor (1949). Warren Buffett, his most famous student, calls The Intelligent Investor “the best book on investing ever written.”
Mr. Market: Graham’s most powerful concept. Imagine the stock market as an emotional business partner who offers different prices every day — sometimes irrationally high, sometimes irrationally low. Your job as a value investor is to buy when Mr. Market is fearful and ignore him when he’s euphoric. Right now, with markets volatile due to global tensions, Mr. Market is offering opportunities to the patient investor.
Margin of Safety: Buy stocks for significantly less than their intrinsic value. The gap between price and value is your protection against errors and unexpected events. Graham wanted at least 30-50% margin. For quality companies with high ROCE and growing earnings, their consistent compounding ability itself provides the margin of safety.
Graham’s Framework for India: Focus on companies with consistent earnings growth, low debt (ideally debt-free), ROCE above 15%, and promoter holding above 50%. Titan Biotech (BSE: 524717) fits these criteria beautifully — currently at ₹504 with ₹2,082 crore market cap, 16.9% ROCE, virtually debt-free (only ₹3 crore borrowings), and 19.16% operating profit margin.
Critical Warning: Whether you’re a defensive or enterprising investor, never gamble with F&O trading. SEBI confirms 90% of F&O traders lose money. Stick to value investing for genuine, long-term wealth creation.
Course Navigation
📚 Watch the Full 30-Episode Course Playlist
🌐 Visit multibaggershares.com for more value investing insights.
Disclaimer
This content is for educational purposes only. The information provided does not constitute investment advice. Always conduct your own research and consult a SEBI-registered financial advisor before making investment decisions. Past performance does not guarantee future results. Investments in the stock market are subject to market risks.
